Chemotherapy before surgery for olfactory neuroblastoma
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether giving chemotherapy before surgery can help treat olfactory neuroblastoma, a rare type of nose cancer. It aims to see how safe and effective this approach is for people with early to advanced tumors that have not spread to other parts of the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with olfactory neuroblastoma (a rare cancer in the nose).
- You must be 18 years old or older.
- Your tumor must be stage T2 to T4 (meaning it's larger or has grown into nearby areas but hasn't spread far).
- You cannot have cancer that has spread to other parts of the body (no distant metastasis).
- You must be willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with olfactory neuroblastoma over time to better understand how the disease behaves and changes. It may help future patients by improving doctors’ knowledge, even if it does not test a new treatment.
This trial tests a new combination of two chemotherapy drugs (Utidelone and Cisplatin) given before surgery for breast cancer. It is for people with early-stage breast cancer that has not spread to other parts of the body, and aims to shrink the tumor to make surgery more effective.
This Phase 3 trial studies a three-step “extra” chemotherapy plan after surgery for people with certain advanced ovarian, fallopian-tube, or primary peritoneal cancers. The goal is to improve outcomes by lowering the chance the cancer comes back.
This trial tests whether giving chemotherapy before surgery can help people with high-risk upper tract urothelial cancer (a cancer in the kidney or ureter). The goal is to see if it improves outcomes for those who are healthy enough to receive cisplatin-based chemotherapy and undergo surgery.
This trial tests the drug nivolumab for people with a rare nasal tumor (olfactory neuroblastoma) that has come back or spread and cannot be treated with surgery or radiation. You must have already tried chemotherapy and it stopped working. The goal is to see if nivolumab can shrink the tumor or slow its growth.
This trial tests whether giving chemotherapy plus immunotherapy (pembrolizumab) before and after surgery can help people whose nasopharyngeal cancer has come back in the same area (locally recurrent). The goal is to see if this approach improves outcomes.
Hear when a new Olfactory Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.